Home Drug Injury Rezulin Liver Damage Settlement

Rezulin Liver Damage Settlement

Rezulin (troglitazone) was a “new” type of antidiabetic medication introduced in 1997 to treat Type 2 diabetes. Originally rejected due to concerns about liver damage, the drug was approved for the market in March 1997, only to be withdrawn in March 2000 due to at least 430 cases of liver failure being reported in patients. Seeger Weiss was a court-appointed member of the Plaintiffs’ Executive Committee, and the firm played a pivotal role in securing an estimated $750 million on behalf of patients who were harmed after taking Rezulin.

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Last updated: Jul 28, 2025
Rezulin Liver Damage Lawsuit Settlement

What’s on this page:

Firm News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More
June 11, 2026
Seven Seeger Weiss Attorneys Named to The 2026 Lawdragon 500 X – The Next Generation Guide

Seeger Weiss is pleased to announce that seven attorneys have been selected for inclusion in The 2026 Lawdragon 500 X – The Next Generation guide, including Steven Daroci, Caleb Seeley, Max Kelly, Audrey Siegel, Frazar Thomas, Hillary Fidler, and Nigel Halliday. Together, they were recognized across plaintiff mass tort, class action, product liability, personal injury, […]

Read More